Tag Archives: BioForward Member News

Read the full press release here Among people with cancer, people diagnosed with COVID-19 were more likely to be Black, have active cancer, have chronic conditions and live in zip codes with median household incomes below $30,000, according to a new study coauthored by two Advocate Aurora Health oncologists. A comparison between those with and without a […]

Read the full press release here Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that is not curable […]

Read the full press release here FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced that it has been awarded funding from the United States Department of Defense to conduct a safety and immunogenicity study of M2SR, the Company’s investigational, supra-seasonal, live, single-replication, intranasal influenza (flu) vaccine. This study […]

Read the full press release here Seven projects – from generating valuable products from the abundant non-food dairy residues that remain after milk is processed into food product, to amplifying UW–Madison doctoral trainees as the new generation of biotechnology industry leaders – have been chosen for funding through the Promoting Industry Collaboration Initiative. These projects […]

Read the full press release here SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors. The financing will support SHINE’s commercialization of its diagnostic […]

Read the full press release here The Advancing a Healthier Wisconsin Endowment (AHW), a statewide philanthropy based at the Medical College of Wisconsin (MCW), has announced the award of $6.5 million to 17 projects aimed at improving health and advancing health equity across Wisconsin. “At the Advancing a Healthier Wisconsin Endowment, we are working to create […]

Read the full press release here The Medical College of Wisconsin (MCW) School of Pharmacy partnered with Nexus Pharmaceuticals, Inc. for a pharmaceutical clinical-use study to compare the use of EMERPHED™, a ready-to-use (RTU) ephedrine sulfate product, to the commercially-used concentrated ephedrine sulfate in a simulated operating room setting using MCW’s Standardized Teaching Assessment Resources (STAR) […]

Read the full press release here Today, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie (NYSE: ABBV), Biogen Inc. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). Managed by the Broad Institute of MIT and Harvard, the […]

Read the full press release here Promega Corporation is setting its most ambitious sustainability targets in the biotechnology manufacturer’s more than 40-year history. The 2021 Corporate Responsibility Report, released today, features new 2030 Environmental Improvement Goals alongside stories of how Promega is supporting researchers, employees and communities during the COVID-19 pandemic. Promega 2030 Environmental Improvement Goals […]